Stock analysts at William Blair boosted their Q4 2025 EPS estimates for shares of Global Industrial in a research report ...

Equities researchers at William Blair issued their FY2029 earnings per share (EPS) estimates for shares of Intellia ...

Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...

Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (NasdaqGM:ALT) with a Market Perform ...

The debate around taxation of cruise operators has been around for years. What would the impact be on the cruise lines?

Fintel reports that on February 28, 2025, William Blair initiated coverage of Corbus Pharmaceuticals Holdings (NasdaqCM:CRBP) ...

We recently published a list of 8 Worst Performing Mutual Funds in 2024. In this article, we are going to take a look at ...

In a report released today, Brian Drab from William Blair maintained a Buy rating on Novanta (NOVT – Research Report). The company’s shares ...

In a report released today, Ryan Daniels from William Blair maintained a Hold rating on Teladoc (TDOC – Research Report). The company’s shares ...

William Blair downgrades Booz Allen, CACI International, Leidos, Parsons and General Dynamics on the heightened risk of ...

The new fund will invest in a niche subset of emerging markets that are 'more challenging for investors to access' ...

The card-issuing company has appointed CFO Mike Milotich as interim CEO as Simon Khalaf steps down. The firm also agreed to ...